Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas J Bond

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Mabs|July 8, 2022
Mechanistic insights into the rational design of masked antibodiesCarolina T Orozco, Manuela Bersellini, Lorraine M Irving, et al.
Chemical Science|September 15, 2023
Stochastic assembly of biomacromolecular complexes: impact and implications on charge interpretation in native mass spectrometryVictor Yin, Paul W A Devine, Janet C Saunders, et al.
Hepatology (Baltimore, Md.)|November 19, 2016
Lipid zonation and phospholipid remodeling in nonalcoholic fatty liver diseaseZoe Hall, Nicholas J Bond, Tom Ashmore, et al.
Communications Biology|November 2, 2021
Antisense oligonucleotide activity in tumour cells is influenced by intracellular LBPA distribution and extracellular vesicle recyclingAlexander N Kapustin, Paul Davey, David Longmire, et al.
Molecular Pharmaceutics|December 16, 2024
Rationalizing mAb Candidate Screening Using a Single Holistic Developability ParameterLeon F Willis, Isabelle Trayton, Janet C Saunders, et al.
Nature Communications|April 15, 2020
An in vivo platform to select and evolve aggregation-resistant proteinsJessica S Ebo, Janet C Saunders, Paul W A Devine, et al.
Mabs|November 12, 2016
The TGF-β inhibitory activity of antibody 37E1B5 depends on its H-CDR2 glycanPing Tsui, Daniel R Higazi, Yanli Wu, et al.
Scientific Reports|December 5, 2018
Engineering of a GLP-1 analogue peptide/anti-PCSK9 antibody fusion for type 2 diabetes treatmentMatthieu Chodorge, Anthony J Celeste, Joseph Grimsby, et al.
Science Translational Medicine|January 25, 2022
The SARS-CoV-2 monoclonal antibody combination, AZD7442, is protective in nonhuman primates and has an extended half-life in humansYueh-Ming Loo, Patrick M McTamney, Rosalinda H Arends, et al.
Nature Communications|September 15, 2015
Oxidation of the alarmin IL-33 regulates ST2-dependent inflammationE Suzanne Cohen, Ian C Scott, Jayesh B Majithiya, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Mabs|July 8, 2022
Mechanistic insights into the rational design of masked antibodiesCarolina T Orozco, Manuela Bersellini, Lorraine M Irving, et al.
Chemical Science|September 15, 2023
Stochastic assembly of biomacromolecular complexes: impact and implications on charge interpretation in native mass spectrometryVictor Yin, Paul W A Devine, Janet C Saunders, et al.
Hepatology (Baltimore, Md.)|November 19, 2016
Lipid zonation and phospholipid remodeling in nonalcoholic fatty liver diseaseZoe Hall, Nicholas J Bond, Tom Ashmore, et al.
Communications Biology|November 2, 2021
Antisense oligonucleotide activity in tumour cells is influenced by intracellular LBPA distribution and extracellular vesicle recyclingAlexander N Kapustin, Paul Davey, David Longmire, et al.
Molecular Pharmaceutics|December 16, 2024
Rationalizing mAb Candidate Screening Using a Single Holistic Developability ParameterLeon F Willis, Isabelle Trayton, Janet C Saunders, et al.
Nature Communications|April 15, 2020
An in vivo platform to select and evolve aggregation-resistant proteinsJessica S Ebo, Janet C Saunders, Paul W A Devine, et al.
Mabs|November 12, 2016
The TGF-β inhibitory activity of antibody 37E1B5 depends on its H-CDR2 glycanPing Tsui, Daniel R Higazi, Yanli Wu, et al.
Scientific Reports|December 5, 2018
Engineering of a GLP-1 analogue peptide/anti-PCSK9 antibody fusion for type 2 diabetes treatmentMatthieu Chodorge, Anthony J Celeste, Joseph Grimsby, et al.
Science Translational Medicine|January 25, 2022
The SARS-CoV-2 monoclonal antibody combination, AZD7442, is protective in nonhuman primates and has an extended half-life in humansYueh-Ming Loo, Patrick M McTamney, Rosalinda H Arends, et al.
Nature Communications|September 15, 2015
Oxidation of the alarmin IL-33 regulates ST2-dependent inflammationE Suzanne Cohen, Ian C Scott, Jayesh B Majithiya, et al.
Pageof 3